These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26635269)

  • 1. Experimental and Clinical Advances in Immunotherapy Strategies for Spinal Cord Injury Target on MAIs and Their Receptors.
    Lu XM; Wei JX; Xiao L; Shu YH; Wang YT
    Curr Pharm Des; 2016; 22(6):728-37. PubMed ID: 26635269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic Acid Vaccine Targeting Nogo-66 Receptor and Paired Immunoglobulin-Like Receptor B as an Immunotherapy Strategy for Spinal Cord Injury in Rats.
    Lu XM; Mao M; Xiao L; Yu Y; He M; Zhao GY; Tang JJ; Feng S; Li S; He CM; Wang YT
    Neurotherapeutics; 2019 Apr; 16(2):381-393. PubMed ID: 30843154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
    Yu P; Huang L; Zou J; Yu Z; Wang Y; Wang X; Xu L; Liu X; Xu XM; Lu PH
    Neurobiol Dis; 2008 Dec; 32(3):535-42. PubMed ID: 18930141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy strategies for spinal cord injury.
    Wang YT; Lu XM; Chen KT; Shu YH; Qiu CH
    Curr Pharm Biotechnol; 2015; 16(6):492-505. PubMed ID: 25860061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of a gold nanoparticle-based adjuvant to improve the therapeutic efficacy of hNgR-Fc protein immunization in spinal cord-injured rats.
    Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Zeng L; Long ZY; Wu YM
    Biomaterials; 2011 Nov; 32(31):7988-98. PubMed ID: 21784510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ameliorative Effects of p75NTR-ED-Fc on Axonal Regeneration and Functional Recovery in Spinal Cord-Injured Rats.
    Wang YT; Lu XM; Zhu F; Huang P; Yu Y; Long ZY; Wu YM
    Mol Neurobiol; 2015 Dec; 52(3):1821-1834. PubMed ID: 25394381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury.
    Walmsley AR; Mir AK
    Curr Pharm Des; 2007; 13(24):2470-84. PubMed ID: 17692015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PirB is a novel potential therapeutic target for enhancing axonal regeneration and synaptic plasticity following CNS injury in mammals.
    Gou Z; Mi Y; Jiang F; Deng B; Yang J; Gou X
    J Drug Target; 2014 Jun; 22(5):365-71. PubMed ID: 24405091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
    Israelsson C; Flygt J; Åstrand E; Kiwanuka O; Bengtsson H; Marklund N
    Restor Neurol Neurosci; 2014; 32(5):717-31. PubMed ID: 25079982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PirB is a functional receptor for myelin inhibitors of axonal regeneration.
    Atwal JK; Pinkston-Gosse J; Syken J; Stawicki S; Wu Y; Shatz C; Tessier-Lavigne M
    Science; 2008 Nov; 322(5903):967-70. PubMed ID: 18988857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE; Liu BP; Park JH; Strittmatter SM
    Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.
    Wang KC; Kim JA; Sivasankaran R; Segal R; He Z
    Nature; 2002 Nov; 420(6911):74-8. PubMed ID: 12422217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
    Zheng B; Atwal J; Ho C; Case L; He XL; Garcia KC; Steward O; Tessier-Lavigne M
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1205-10. PubMed ID: 15647357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic DNA vaccination as a repair strategy following spinal cord injury.
    Kou SB; Xu G; Jiang XD; Xu RX; Tang YP; Xu G; Cai YQ; Du MX; Xiao ZC
    Cell Mol Neurobiol; 2010 Mar; 30(2):275-82. PubMed ID: 19757023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with a Nogo-A-derived peptide after incomplete spinal-cord injury promotes recovery via a T-cell-mediated neuroprotective response: comparison with other myelin antigens.
    Hauben E; Ibarra A; Mizrahi T; Barouch R; Agranov E; Schwartz M
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):15173-8. PubMed ID: 11752461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
    Saha N; Kolev M; Nikolov DB
    Neurosci Res; 2014 Oct; 87():1-7. PubMed ID: 24956133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells.
    Nyatia E; Lang DM
    Res Vet Sci; 2007 Dec; 83(3):287-301. PubMed ID: 17428512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury.
    Li S; Kim JE; Budel S; Hampton TG; Strittmatter SM
    Mol Cell Neurosci; 2005 May; 29(1):26-39. PubMed ID: 15866044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside mediate the interaction between Nogo receptor 1 and LINGO-1.
    Saha N; Kolev MV; Semavina M; Himanen J; Nikolov DB
    Biochem Biophys Res Commun; 2011 Sep; 413(1):92-7. PubMed ID: 21872576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.
    Wang KC; Koprivica V; Kim JA; Sivasankaran R; Guo Y; Neve RL; He Z
    Nature; 2002 Jun; 417(6892):941-4. PubMed ID: 12068310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.